UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019332
Receipt number R000022159
Scientific Title Volume expanding effect and peripheral perfusion of 130 HES in the patients during perioperative period
Date of disclosure of the study information 2015/10/13
Last modified on 2016/06/27 16:23:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Volume expanding effect and peripheral perfusion of 130 HES in the patients during perioperative period

Acronym

Efficacy of 130 HES in the patients during perioperative period

Scientific Title

Volume expanding effect and peripheral perfusion of 130 HES in the patients during perioperative period

Scientific Title:Acronym

Efficacy of 130 HES in the patients during perioperative period

Region

Japan


Condition

Condition

Perioperative patients

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will compare the effect of 130 HES in volume expansion, hemodynamic parameters and peripheral perfusion with that of 70 HES and bicarbonated Ringer solution.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Increase of circulation blood volume at 10 minutes after the administration of 130 HES, 70HES or bicarbonated Ringer solution.

Key secondary outcomes

Changes of blood pressure, heart rate, peripheral perfusion index and hemoglobin at 10 minutes after the administration of 130 HES, 70HES or bicarbonated Ringer solution.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Intravenous administration of 500 ml of 130 HES in 10 minutes

Interventions/Control_2

Intravenous administration of 500 ml of 70 HES in 10 minutes

Interventions/Control_3

Intravenous administration of 500 ml of bicarbonated Ringer solution in 10 minutes

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with 1-2 of ASA physical status in elective surgery.

Key exclusion criteria

Patients with cardiovascular disease, hemorrhage and/or dehydration.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroaki Toyama

Organization

Tohoku University hospital

Division name

Department of Anesthesiology

Zip code


Address

1-1 Seiryomachi, Aoba-ku, Sendai, Japan

TEL

022-717-7321

Email

h-toyama@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroaki Toyama

Organization

Tohoku University Hospital

Division name

Department of Anesthesiology

Zip code


Address

1-1 Seiryomachi, Aoba-ku, Sendai, Japan

TEL

022-717-7321

Homepage URL


Email

h-toyama@umin.ac.jp


Sponsor or person

Institute

Department of Anesthesiology, Tohoku University Hospital

Institute

Department

Personal name



Funding Source

Organization

Department of Anesthesiology, Tohoku University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

None

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東北大学病院(宮城県)


Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 11 Month 01 Day

Last follow-up date

2016 Year 02 Month 28 Day

Date of closure to data entry

2016 Year 02 Month 28 Day

Date trial data considered complete

2016 Year 02 Month 28 Day

Date analysis concluded

2016 Year 02 Month 28 Day


Other

Other related information



Management information

Registered date

2015 Year 10 Month 13 Day

Last modified on

2016 Year 06 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022159


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name